Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
Department of Health and Human Services
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) seeks research project (R01) grant applications describing projects that integrate imaging and fluid-based tumor monitoring (liquid biopsy) assays during cancer therapy in patients to determine the optimal use of those modalities in the characterization of therapy response and/or emergence of resistance.
Funding
Award size
$100K – $1M
Award ceiling
500000
Type
Grant
Dates
Deadline
Later
Posted
11/06/2024
Closes
2028-01-07
Eligibility
Eligibility
Small businessesCity or township governmentsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesIndependent school districtsNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationCounty governmentsSpecial district governmentsFor profit organizations other than small businessesPrivate institutions of higher educationState governmentsNonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationOthers (see text field entitled "Additional Information on Eligibility" for clarification)Native American tribal organizations (other than Federally recognized tribal governments)
Program
Funding area
Education - EDHealth - HL
Opportunity #
PAR-25-175
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov